$MYOV $PFE 📰 Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study Evaluating Contraceptive Efficacy of Once-Daily Relugolix Combination Tablet

https://quantisnow.com/insight/606413?s=s

#majorpharmaceuticals #healthcare

$ATNF 📜 SEC Form 4: Marc Feldmann was granted 20,910 units of Common Stock, increasing direct ownership by 0.81% to 2,617,758 units

https://quantisnow.com/insight/604824?s=s

#majorpharmaceuticals #healthcare

$ATNF 📜 SEC Form 4: B. Jonathan Rothbard was granted 24,307 units of Common Stock, increasing direct ownership by 5% to 560,449 units

https://quantisnow.com/insight/604815?s=s

#majorpharmaceuticals #healthcare

$AFMD 📜 SEC Form 6-K filed by Affimed N.V.

https://quantisnow.com/insight/603085?s=s

#majorpharmaceuticals #healthcare

$AFMD 📰 Affimed Announces Presentation at AACR Highlighting Initial Data from Phase 1 Study of Cord Blood-derived Natural Killer Cells Pre-complexed with Innate Cell Engager AFM13

https://quantisnow.com/insight/602926?s=s

#majorpharmaceuticals #healthcare

$ATNF 📜 SEC Form 4: Lawrence Steinman was granted 22,585 units of Common Stock, increasing direct ownership by 4% to 592,358 units

https://quantisnow.com/insight/599421?s=s

#majorpharmaceuticals #healthcare

$AFMD 📃 Affimed to Report Full Year 2020 Financial Results &; Corporate Update on April 15, 2021

https://quantisnow.com/insight/598923?s=s

#majorpharmaceuticals #healthcare

$MRK 📋 RBC Capital Mkts resumed coverage on Merck with a new price target

https://quantisnow.com/insight/594214?s=s

#majorpharmaceuticals #healthcare

$ONCT 📡 Oppenheimer initiated coverage on Oncternal Therapeutics with a new price target

https://quantisnow.com/insight/594091?s=s

#majorpharmaceuticals #healthcare

$AQST 📜 SEC Form EFFECT filed by Aquestive Therapeutics, Inc.

https://quantisnow.com/insight/588886?s=s

#majorpharmaceuticals #healthcare

$AZN 📜 SEC Form 6-K filed by Astrazeneca PLC

https://quantisnow.com/insight/514319?s=s

#healthcare #majorpharmaceuticals